wx390
Showing 1 - 4 of 4
Solid Tumor Trial in Shanghai (WX390)
Recruiting
- Solid Tumor
- WX390
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 2, 2023
Solid Tumor Trial in Changchun (WX390, Toripalimab)
Recruiting
- Solid Tumor
- WX390
- Toripalimab
-
Changchun, Jilin, Chinathe first affiliated hospital of Jilin university
Nov 3, 2023
PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)
Completed
- PIK3CA Mutation-Related Tumors
- WX390
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 9, 2023
Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)
Recruiting
- Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
- WX390
- Toripalimab
-
Shanghai, Shanghai, ChinaThe Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023